The market cut this builder in half. Its earnings estimates went up.


 
<[link removed]> 



You are receiving this email because you are subscribed to Daily Wall Street
Alerts, a publication from Behind the Markets. If you no longer wish to receive
these emails, pleaseunsubscribe
<[link removed]>
here.




LEAD STORY


<[link removed]>
8 analysts. 8 Strong Buys. An 80% gap.
<[link removed]>

Here’s a question almost nobody asks about a stock’s “upside”: where did the
number come from? When you read that analysts see 50% upside, that’s just a
fraction — the average price target (what the analysts who study the company
believe a share will be worth in a year) divided by today’s price. And a gap
that big can open two very different ways. Way one: the stock runs hot and
analysts chase it, raising targets to keep up. That’s enthusiasm — and
enthusiasm follows price. Way two: the price falls and the analysts refuse to
follow. The company keeps reporting good numbers, the research desks keep their
Buy ratings, and the gap opens from below. That’s not enthusiasm. That’s a
disagreement — Wall Street’s analysts telling the market, in writing, “you’ve
got this one wrong.” Tonight, three disagreements. Three profitable, growing
companies — every one rated a Buy or better by nearly every analyst covering it
— whose stocks have been marked down 40% or more from their highs while the…
READ FULL ARTICLE →
<[link removed]>



FEATURED ANALYSIS


AI Is Still Spending—Biotech Is Still Proving
<[link removed]>

The market wants one clean story. This week it got two messy ones: AI spending
still looks enormous, while biotech keeps reminding investors that science does
not follow a quarterly calendar. That is why we are separating the themes
instead of throwing every “innovation” stock into one basket. Tech can reward
scale and execution. Biotech can reward a clinical or regulatory
breakthrough—but it can also punish investors who mistake a press release for a
product. Reuters reported that Nvidia’s…
READ FULL ARTICLE →
<[link removed]>




MORE HEADLINES


1. Wall Street's Estimate for Walmart Sits Exactly on Top of Walmart's Own
Guidance. Last Time That Happened, the Stock Fell 4%.
<[link removed]>
2. Cisco Just Finished the Best Year in Its History and Guided $1.3 Billion
Above Estimates. The Stock Fell 10%.
<[link removed]>
3. CoreWeave's Revenue Doubled and the Stock Jumped 21%. Its Debt Grew by $12
Billion in Three Months.
<[link removed]>
4. The Biggest Threat to Your Portfolio Isn't Iran
<[link removed]>


 



Behind the Markets · Text Alerts



Stay Ahead of the Market



The best investment opportunities don't wait. Get our research and stock ideas
delivered straight to your smartphone—so you never miss a market-moving
opportunity. Our text alerts ensure you see timely stock ideas and professional
research reports instantly, whether you're in a meeting, commuting, or away
from your desk.

GET TEXT ALERTS FROM BEHIND THE MARKETS (FREE) →
<[link removed]>

 

 
<[link removed]>

YOUR DAILY MARKET INTELLIGENCE



You're receiving this because you signed up for the Daily Wall Street Alerts
newsletter.

Daily Wall Street Alerts is a Behind the Markets <[link removed]>
Publication.
Behind the Markets, LLC
4260 NW 1st Ave #55, Boca Raton, FL 33431




Unsubscribe
<[link removed]>


Terms of Use <[link removed]>


Privacy Policy <[link removed]>






© 2026 Behind the Markets. All rights reserved.